MeSH D001201 - ascites
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Hydrochlorothiazide, Amiloride | Amiloride Hydrochlorothiazide |  | 1988-04-17 |  |  |
| Spironolactone | Spironolactone |  | 1982-01-01 |  |  | |
| Hydrochlorothiazide, Spironolactone | Spironolactone W/ Hydrochlorothiazide |  | 1982-05-24 |  |  | |
| Mylan | Furosemide | Furosemide |  | 1986-10-29 |  |  |
| Spironolactone | Spironolactone |  | 2001-08-20 |  |  | |
| Hydrochlorothiazide, Spironolactone | Spironolactone Hydrochlorothiazide |  | 1982-01-01 |  |  | |
| AstraZeneca | Furosemide | Furosemide |  | 1985-09-09 |  |  |
| Sanofi | Furosemide | Lasix |  | 1982-01-01 |  |  |
| Wyeth | Furosemide | Furosemide |  | 1982-07-20 |  |  |
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
67%2/3
Phase 2
52%14/27
Phase 3
62%13/21
Approved: 7Overall Success rate: 21%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use